<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37298220</PMID><DateCompleted><Year>2023</Year><Month>06</Month><Day>12</Day></DateCompleted><DateRevised><Year>2023</Year><Month>06</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>11</Issue><PubDate><Year>2023</Year><Month>May</Month><Day>25</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Simulation of Hemorrhage Pathogenesis in Mice through Dual Stimulation with Dengue Envelope Protein Domain III-Coated Nanoparticles and Antiplatelet Antibody.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">9270</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms24119270</ELocationID><Abstract><AbstractText>Dengue hemorrhagic fever (DHF) is a severe form of dengue virus (DENV) infection that can lead to abnormal immune responses, endothelial vascular dysfunction, and hemorrhage pathogenesis. The virion-associated envelope protein domain III (EIII) is thought to play a role in the virulence of DENV by damaging endothelial cells. However, it is unclear whether EIII-coated nanoparticles simulating DENV virus particles could cause a more severe pathogenesis than soluble EIII alone. This study aimed to investigate whether EIII-coated silica nanoparticles (EIII-SNPs) could elicit greater cytotoxicity in endothelial cells and hemorrhage pathogenesis in mice compared to EIII or silica nanoparticles alone. The main methods included in vitro assays to assess cytotoxicity and in vivo experiments to examine hemorrhage pathogenesis in mice. EIII-SNPs induced greater endothelial cytotoxicity in vitro than EIII or silica nanoparticles alone. Two-hit combined treatment with EIII-SNPs and antiplatelet antibodies to simulate DHF hemorrhage pathogenesis during secondary DENV infections resulted in higher endothelial cytotoxicity than either treatment alone. In mouse experiments, two-hit combined treatment with EIII-SNPs and antiplatelet antibodies resulted in more severe hemorrhage pathogenesis compared to single treatments of EIII, EIII-SNPs, or antiplatelet antibodies alone. These findings suggest that EIII-coated nanoparticles are more cytotoxic than soluble EIII and could be used to develop a tentative dengue two-hit hemorrhage pathogenesis model in mice. Additionally, our results indicated that EIII-containing DENV particles could potentially exacerbate hemorrhage pathogenesis in DHF patients who have antiplatelet antibodies, highlighting the need for further research on the potential role of EIII in DHF pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lien</LastName><ForeName>Te-Sheng</ForeName><Initials>TS</Initials><AffiliationInfo><Affiliation>Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien 970, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sun</LastName><ForeName>Der-Shan</ForeName><Initials>DS</Initials><Identifier Source="ORCID">0000-0002-1994-7355</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien 970, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Wen-Sheng</ForeName><Initials>WS</Initials><Identifier Source="ORCID">0000-0002-8983-6458</Identifier><AffiliationInfo><Affiliation>Division of General Surgery, Department of Surgery, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Hsin-Hou</ForeName><Initials>HH</Initials><Identifier Source="ORCID">0000-0002-8731-3485</Identifier><AffiliationInfo><Affiliation>Department of Molecular Biology and Human Genetics, Tzu-Chi University, Hualien 970, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>111-2320-B-320-006-MY3</GrantID><Agency>National Science and Technology Council, Taiwan</Agency><Country/></Grant><Grant><GrantID>TCMMP108-04; TCMMP 111-01; TCAS-112-02; TCAS-111-02</GrantID><Agency>Tzu-Chi Medical Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>05</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="Y">Dengue Virus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072417" MajorTopicYN="N">Protein Domains</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="Y">Dengue</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anti-coagulants</Keyword><Keyword MajorTopicYN="N">antiplatelet antibody</Keyword><Keyword MajorTopicYN="N">cytokines</Keyword><Keyword MajorTopicYN="N">dengue envelope protein domain III</Keyword><Keyword MajorTopicYN="N">dengue hemorrhage fever</Keyword><Keyword MajorTopicYN="N">dengue virus</Keyword><Keyword MajorTopicYN="N">hemorrhage</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">silica nanoparticles</Keyword><Keyword MajorTopicYN="N">two-hit model</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>5</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>6</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>15</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>6</Month><Day>10</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37298220</ArticleId><ArticleId IdType="pmc">PMC10253347</ArticleId><ArticleId IdType="doi">10.3390/ijms24119270</ArticleId><ArticleId IdType="pii">ijms24119270</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gubler D.J. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 1998;11:480&#x2013;496. doi: 10.1128/CMR.11.3.480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.11.3.480</ArticleId><ArticleId IdType="pmc">PMC88892</ArticleId><ArticleId IdType="pubmed">9665979</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasan S., Jamdar S.F., Alalowi M., Al Ageel Al Beaiji S.M. Dengue virus: A global human threat: Review of literature. J. Int. Soc. Prev. Community Dent. 2016;6:1&#x2013;6. doi: 10.4103/2231-0762.175416.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2231-0762.175416</ArticleId><ArticleId IdType="pmc">PMC4784057</ArticleId><ArticleId IdType="pubmed">27011925</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W.H., Urbina A.N., Chang M.R., Assavalapsakul W., Lu P.L., Chen Y.H., Wang S.F. Dengue hemorrhagic fever&#x2013;A systemic literature review of current perspectives on pathogenesis, prevention and control. J. Microbiol. Immunol. Infect. 2020;53:963&#x2013;978. doi: 10.1016/j.jmii.2020.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmii.2020.03.007</ArticleId><ArticleId IdType="pubmed">32265181</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.F., Lei H.Y., Liu C.C., Liu H.S., Yeh T.M., Wang S.T., Yang T.I., Sheu F.C., Kuo C.F., Lin Y.S. Generation of IgM anti-platelet autoantibody in dengue patients. J. Med. Virol. 2001;63:143&#x2013;149. doi: 10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1096-9071(20000201)63:2&lt;143::AID-JMV1009&gt;3.0.CO;2-L</ArticleId><ArticleId IdType="pubmed">11170051</ArticleId></ArticleIdList></Reference><Reference><Citation>Vo H.T.M., Duong V., Ly S., Li Q.Z., Dussart P., Cantaert T. Autoantibody Profiling in Plasma of Dengue Virus-Infected Individuals. Pathogens. 2020;9:1060. doi: 10.3390/pathogens9121060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens9121060</ArticleId><ArticleId IdType="pmc">PMC7766539</ArticleId><ArticleId IdType="pubmed">33352902</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien T.S., Sun D.S., Chang C.M., Wu C.Y., Dai M.S., Chan H., Wu W.S., Su S.H., Lin Y.Y., Chang H.H. Dengue virus and antiplatelet autoantibodies synergistically induce haemorrhage through Nlrp3-inflammasome and FcgammaRIII. Thromb. Haemost. 2015;113:1060&#x2013;1070.</Citation><ArticleIdList><ArticleId IdType="pubmed">25740324</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien T.S., Sun D.S., Wu C.Y., Chang H.H. Exposure to Dengue Envelope Protein Domain III Induces Nlrp3 Inflammasome-Dependent Endothelial Dysfunction and Hemorrhage in Mice. Front. Immunol. 2021;12:617251. doi: 10.3389/fimmu.2021.617251.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.617251</ArticleId><ArticleId IdType="pmc">PMC7947687</ArticleId><ArticleId IdType="pubmed">33717109</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D.S., Chang Y.C., Lien T.S., King C.C., Shih Y.L., Huang H.S., Wang T.Y., Li C.R., Lee C.C., Hsu P.N., et al. Endothelial Cell Sensitization by Death Receptor Fractions of an Anti-Dengue Nonstructural Protein 1 Antibody Induced Plasma Leakage, Coagulopathy, and Mortality in Mice. J. Immunol. 2015;195:2743&#x2013;2753. doi: 10.4049/jimmunol.1500136.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1500136</ArticleId><ArticleId IdType="pubmed">26259584</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D.S., King C.C., Huang H.S., Shih Y.L., Lee C.C., Tsai W.J., Yu C.C., Chang H.H. Antiplatelet autoantibodies elicited by dengue virus non-structural protein 1 cause thrombocytopenia and mortality in mice. J. Thromb. Haemost. 2007;5:2291&#x2013;2299. doi: 10.1111/j.1538-7836.2007.02754.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2007.02754.x</ArticleId><ArticleId IdType="pubmed">17958746</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie S., Xing Y., Kim G.J., Simons J.W. Nanotechnology applications in cancer. Annu. Rev. Biomed. Eng. 2007;9:257&#x2013;288. doi: 10.1146/annurev.bioeng.9.060906.152025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.bioeng.9.060906.152025</ArticleId><ArticleId IdType="pubmed">17439359</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou J.W., Chang H.H. Bactericidal effects and mechanisms of visible light-responsive titanium dioxide photocatalysts on pathogenic bacteria. Arch Immunol. Ther. Exp. 2012;60:267&#x2013;275. doi: 10.1007/s00005-012-0178-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00005-012-0178-x</ArticleId><ArticleId IdType="pubmed">22678625</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou J.-W., Gu M.-H., Chen Y.-K., Chen W.-Y., Chen Y.-C., Tseng Y.-H., Hung Y.-J., Chang H.-H. Visible light responsive photocatalyst induces progressive and apical-terminus preferential damages on Escherichia coli surfaces. PLoS ONE. 2011;6:e19982. doi: 10.1371/journal.pone.0019982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0019982</ArticleId><ArticleId IdType="pmc">PMC3093399</ArticleId><ArticleId IdType="pubmed">21589873</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho Y.Y., Sun D.S., Chang H.H. Silver Nanoparticles Protect Skin from Ultraviolet B-Induced Damage in Mice. Int. J. Mol. Sci. 2020;21:7082. doi: 10.3390/ijms21197082.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21197082</ArticleId><ArticleId IdType="pmc">PMC7582269</ArticleId><ArticleId IdType="pubmed">32992921</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C.Y., Yu W.S., Liu G.C., Hung S.C., Chang J.H., Chang J.C., Cheng C.L., Sun D.S., Lin M.D., Lin W.Y., et al. Opportunistic gill infection is associated with TiO2 nanoparticle-induced mortality in zebrafish. PLoS ONE. 2021;16:e0247859. doi: 10.1371/journal.pone.0247859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0247859</ArticleId><ArticleId IdType="pmc">PMC8291654</ArticleId><ArticleId IdType="pubmed">34283836</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.-C., Tsai L.-W., Perevedentseva E., Chang H.-H., Lin C.-H., Sun D.-S., Lugovtsov A.E., Priezzhev A., Mona J., Cheng C.-L. The influence of nanodiamond on the oxygenation states and micro rheological properties of human red blood cells in vitro. J. Biomed. Opt. 2012;17:1015121&#x2013;1015129. doi: 10.1117/1.JBO.17.10.101512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1117/1.JBO.17.10.101512</ArticleId><ArticleId IdType="pubmed">23223988</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseng P.H., Sie Z.L., Liu M.C., Lin H.S., Yang W.Y., Lin T.Y., Hsieh H.P., Hung S.S., Cheng C.L., Wang H.D., et al. Identification of two novel small compounds that inhibit liver cancer formation in zebrafish and analysis of their conjugation to nanodiamonds to further reduce toxicity. Adv. Ther. 2019;2:1900105. doi: 10.1002/adtp.201900105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adtp.201900105</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh M., O&#x2019;Hagan D. Advances in vaccine adjuvants. Nat. Biotechnol. 1999;17:1075&#x2013;1081. doi: 10.1038/15058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/15058</ArticleId><ArticleId IdType="pubmed">10545912</ArticleId></ArticleIdList></Reference><Reference><Citation>Champion J.A., Mitragotri S. Role of target geometry in phagocytosis. Proc. Natl. Acad. Sci. USA. 2006;103:4930&#x2013;4934. doi: 10.1073/pnas.0600997103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0600997103</ArticleId><ArticleId IdType="pmc">PMC1458772</ArticleId><ArticleId IdType="pubmed">16549762</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadar M., Chakraborty S., Dhama K., Prasad M., Khandia R., Hassan S., Munjal A., Tiwari R., Karthik K., Kumar D., et al. Advances in Designing and Developing Vaccines, Drugs and Therapeutic Approaches to Counter Human Papilloma Virus. Front. Immunol. 2018;9:2478. doi: 10.3389/fimmu.2018.02478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.02478</ArticleId><ArticleId IdType="pmc">PMC6240620</ArticleId><ArticleId IdType="pubmed">30483247</ArticleId></ArticleIdList></Reference><Reference><Citation>Irvine D.J., Swartz M.A., Szeto G.L. Engineering synthetic vaccines using cues from natural immunity. Nat. Mater. 2013;12:978&#x2013;990. doi: 10.1038/nmat3775.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmat3775</ArticleId><ArticleId IdType="pmc">PMC3928825</ArticleId><ArticleId IdType="pubmed">24150416</ArticleId></ArticleIdList></Reference><Reference><Citation>Perotti M., Perez L. Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV. Viruses. 2019;12:35. doi: 10.3390/v12010035.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12010035</ArticleId><ArticleId IdType="pmc">PMC7019358</ArticleId><ArticleId IdType="pubmed">31905677</ArticleId></ArticleIdList></Reference><Reference><Citation>Nooraei S., Bahrulolum H., Hoseini Z.S., Katalani C., Hajizade A., Easton A.J., Ahmadian G. Virus-like particles: Preparation, immunogenicity and their roles as nanovaccines and drug nanocarriers. J. Nanobiotechnol. 2021;19:59. doi: 10.1186/s12951-021-00806-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12951-021-00806-7</ArticleId><ArticleId IdType="pmc">PMC7905985</ArticleId><ArticleId IdType="pubmed">33632278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K.R., Lee A.S., Kim S.M., Heo H.R., Kim C.S. Virus-like nanoparticles as a theranostic platform for cancer. Front. Bioeng. Biotechnol. 2022;10:1106767. doi: 10.3389/fbioe.2022.1106767.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fbioe.2022.1106767</ArticleId><ArticleId IdType="pmc">PMC9878189</ArticleId><ArticleId IdType="pubmed">36714624</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejia-Mendez J.L., Vazquez-Duhalt R., Hernandez L.R., Sanchez-Arreola E., Bach H. Virus-Like Particles: Fundamentals and Biomedical Applications. Int. J. Mol. Sci. 2022;23:8579. doi: 10.3390/ijms23158579.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23158579</ArticleId><ArticleId IdType="pmc">PMC9369363</ArticleId><ArticleId IdType="pubmed">35955711</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai C.L., Sun D.S., Su M.T., Lien T.S., Chen Y.H., Lin C.Y., Huang C.H., King C.C., Li C.R., Chen T.H., et al. Suppressed humoral immunity is associated with dengue nonstructural protein NS1-elicited anti-death receptor antibody fractions in mice. Sci. Rep. 2020;10:6294. doi: 10.1038/s41598-020-62958-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62958-0</ArticleId><ArticleId IdType="pmc">PMC7156414</ArticleId><ArticleId IdType="pubmed">32286343</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien T.S., Chan H., Sun D.S., Wu J.C., Lin Y.Y., Lin G.L., Chang H.H. Exposure of Platelets to Dengue Virus and Envelope Protein Domain III Induces Nlrp3 Inflammasome-Dependent Platelet Cell Death and Thrombocytopenia in Mice. Front. Immunol. 2021;12:616394. doi: 10.3389/fimmu.2021.616394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.616394</ArticleId><ArticleId IdType="pmc">PMC8118162</ArticleId><ArticleId IdType="pubmed">33995345</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien T.S., Sun D.S., Hung S.C., Wu W.S., Chang H.H. Dengue virus envelope protein domain III induces Nlrp3 inflammasome-dependent NETosis-mediated inflammation in mice. Front. Immunol. 2021;12:618577. doi: 10.3389/fimmu.2021.618577.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.618577</ArticleId><ArticleId IdType="pmc">PMC8009969</ArticleId><ArticleId IdType="pubmed">33815373</ArticleId></ArticleIdList></Reference><Reference><Citation>Srikiatkhachorn A., Mathew A., Rothman A.L. Immune-mediated cytokine storm and its role in severe dengue. Semin. Immunopathol. 2017;39:563&#x2013;574. doi: 10.1007/s00281-017-0625-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00281-017-0625-1</ArticleId><ArticleId IdType="pmc">PMC5496927</ArticleId><ArticleId IdType="pubmed">28401256</ArticleId></ArticleIdList></Reference><Reference><Citation>Dayarathna S., Jeewandara C., Gomes L., Somathilaka G., Jayathilaka D., Vimalachandran V., Wijewickrama A., Narangoda E., Idampitiya D., Ogg G.S., et al. Similarities and differences between the &#x2019;cytokine storms&#x2019; in acute dengue and COVID-19. Sci. Rep. 2020;10:19839. doi: 10.1038/s41598-020-76836-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-76836-2</ArticleId><ArticleId IdType="pmc">PMC7670444</ArticleId><ArticleId IdType="pubmed">33199778</ArticleId></ArticleIdList></Reference><Reference><Citation>Puc I., Ho T.C., Yen K.L., Vats A., Tsai J.J., Chen P.L., Chien Y.W., Lo Y.C., Perng G.C. Cytokine Signature of Dengue Patients at Different Severity of the Disease. Int. J. Mol. Sci. 2021;22:2879. doi: 10.3390/ijms22062879.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22062879</ArticleId><ArticleId IdType="pmc">PMC7999441</ArticleId><ArticleId IdType="pubmed">33809042</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam A., Cockcroft C., Elshazly S., Ahmed J., Joyce K., Mahfuz H., Islam T., Rashid H., Laher I. Coagulopathy of Dengue and COVID-19: Clinical Considerations. Trop Med. Infect. Dis. 2022;7:210. doi: 10.3390/tropicalmed7090210.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/tropicalmed7090210</ArticleId><ArticleId IdType="pmc">PMC9500638</ArticleId><ArticleId IdType="pubmed">36136621</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M., Scully M. How I treat disseminated intravascular coagulation. Blood. 2018;131:845&#x2013;854. doi: 10.1182/blood-2017-10-804096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2017-10-804096</ArticleId><ArticleId IdType="pubmed">29255070</ArticleId></ArticleIdList></Reference><Reference><Citation>Athanasiou E., Agallou M., Tastsoglou S., Kammona O., Hatzigeorgiou A., Kiparissides C., Karagouni E. A Poly(Lactic-co-Glycolic) Acid Nanovaccine Based on Chimeric Peptides from Different Leishmania infantum Proteins Induces Dendritic Cells Maturation and Promotes Peptide-Specific IFNgamma-Producing CD8+ T Cells Essential for the Protection against Experimental Visceral Leishmaniasis. Front. Immunol. 2017;8:684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5468442</ArticleId><ArticleId IdType="pubmed">28659922</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H.J., Han S.E., Im S., Lee Y., Kim Y.B., Chun T., Oh Y.K. Maltosylated polyethylenimine-based triple nanocomplexes of human papillomavirus 16L1 protein and DNA as a vaccine co-delivery system. Biomaterials. 2011;32:4621&#x2013;4629. doi: 10.1016/j.biomaterials.2011.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2011.03.004</ArticleId><ArticleId IdType="pubmed">21440296</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong S., Leroueil P.R., Majoros I.J., Orr B.G., Baker J.R., Jr., Banaszak Holl M.M. The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform. Chem. Biol. 2007;14:107&#x2013;115. doi: 10.1016/j.chembiol.2006.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chembiol.2006.11.015</ArticleId><ArticleId IdType="pubmed">17254956</ArticleId></ArticleIdList></Reference><Reference><Citation>Silpe J.E., Sumit M., Thomas T.P., Huang B., Kotlyar A., van Dongen M.A., Banaszak Holl M.M., Orr B.G., Choi S.K. Avidity modulation of folate-targeted multivalent dendrimers for evaluating biophysical models of cancer targeting nanoparticles. ACS Chem. Biol. 2013;8:2063&#x2013;2071. doi: 10.1021/cb400258d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/cb400258d</ArticleId><ArticleId IdType="pmc">PMC3783574</ArticleId><ArticleId IdType="pubmed">23855478</ArticleId></ArticleIdList></Reference><Reference><Citation>Deci M.B., Liu M., Dinh Q.T., Nguyen J. Precision engineering of targeted nanocarriers. Wiley Interdiscip. Rev. Nanomed Nanobiotechnol. 2018;10:e1511. doi: 10.1002/wnan.1511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/wnan.1511</ArticleId><ArticleId IdType="pmc">PMC6089677</ArticleId><ArticleId IdType="pubmed">29436157</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead S.B. Dengue. Lancet. 2007;370:1644&#x2013;1652. doi: 10.1016/S0140-6736(07)61687-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(07)61687-0</ArticleId><ArticleId IdType="pubmed">17993365</ArticleId></ArticleIdList></Reference><Reference><Citation>Brozna J.P. Shwartzman reaction. Semin. Thromb. Hemost. 1990;16:326&#x2013;332. doi: 10.1055/s-2007-1002685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-2007-1002685</ArticleId><ArticleId IdType="pubmed">2281321</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayesh M.E.H., Tsukiyama-Kohara K. Mammalian animal models for dengue virus infection: A recent overview. Arch. Virol. 2022;167:31&#x2013;44. doi: 10.1007/s00705-021-05298-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-021-05298-2</ArticleId><ArticleId IdType="pmc">PMC8579898</ArticleId><ArticleId IdType="pubmed">34761286</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . Dengue Haemorrhagic Fever: Diagnosis, Treatment, Prevention and Control. 2nd ed. World Health Organization; Geneva, Switzerland: 1997. pp. 12&#x2013;23. Chapter 2.</Citation></Reference><Reference><Citation>WHO . Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control. World Health Organization; Geneva, Switzerland: 2009.</Citation><ArticleIdList><ArticleId IdType="pubmed">23762963</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebeau G., Lagrave A., Ogire E., Grondin L., Seriacaroupin S., Moutoussamy C., Mavingui P., Hoarau J.J., Roche M., Krejbich-Trotot P., et al. Viral Toxin NS1 Implication in Dengue Pathogenesis Making It a Pivotal Target in Development of Efficient Vaccine. Vaccines. 2021;9:946. doi: 10.3390/vaccines9090946.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9090946</ArticleId><ArticleId IdType="pmc">PMC8471935</ArticleId><ArticleId IdType="pubmed">34579183</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H.S., Sun D.S., Lien T.S., Chang H.H. Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice. Blood. 2010;116:5002&#x2013;5009. doi: 10.1182/blood-2010-03-275123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-03-275123</ArticleId><ArticleId IdType="pubmed">20699442</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin G.L., Chang H.H., Lien T.S., Chen P.K., Chan H., Su M.T., Liao C.Y., Sun D.S. Suppressive effect of dengue virus envelope protein domain III on megakaryopoiesis. Virulence. 2017;8:1719&#x2013;1731. doi: 10.1080/21505594.2017.1343769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2017.1343769</ArticleId><ArticleId IdType="pmc">PMC5810469</ArticleId><ArticleId IdType="pubmed">28622093</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D.S., Kau J.H., Huang H.H., Tseng Y.H., Wu W.S., Chang H.H. Antibacterial Properties of Visible-Light-Responsive Carbon-Containing Titanium Dioxide Photocatalytic Nanoparticles against Anthrax. Nanomaterials. 2016;6:237. doi: 10.3390/nano6120237.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nano6120237</ArticleId><ArticleId IdType="pmc">PMC5302719</ArticleId><ArticleId IdType="pubmed">28335365</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H.H., Shyu H.F., Wang Y.M., Sun D.S., Shyu R.H., Tang S.S., Huang Y.S. Facilitation of cell adhesion by immobilized dengue viral nonstructural protein 1 (NS1): Arginine-glycine-aspartic acid structural mimicry within the dengue viral NS1 antigen. J. Infect. Dis. 2002;186:743&#x2013;751. doi: 10.1086/342600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/342600</ArticleId><ArticleId IdType="pubmed">12198607</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung S.C., Ke L.C., Lien T.S., Huang H.S., Sun D.S., Cheng C.L., Chang H.H. Nanodiamond-Induced Thrombocytopenia in Mice Involve P-Selectin-Dependent Nlrp3 Inflammasome-Mediated Platelet Aggregation, Pyroptosis and Apoptosis. Front. Immunol. 2022;13:806686. doi: 10.3389/fimmu.2022.806686.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.806686</ArticleId><ArticleId IdType="pmc">PMC9013758</ArticleId><ArticleId IdType="pubmed">35444640</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D.S., Chang Y.W., Kau J.H., Huang H.H., Ho P.H., Tzeng Y.J., Chang H.H. Soluble P-selectin rescues mice from anthrax lethal toxin-induced mortality through PSGL-1 pathway-mediated correction of hemostasis. Virulence. 2017;8:1216&#x2013;1228. doi: 10.1080/21505594.2017.1282027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21505594.2017.1282027</ArticleId><ArticleId IdType="pmc">PMC5711406</ArticleId><ArticleId IdType="pubmed">28102766</ArticleId></ArticleIdList></Reference><Reference><Citation>Kau J.H., Shih Y.L., Lien T.S., Lee C.C., Huang H.H., Lin H.C., Sun D.S., Chang H.H. Activated protein C ameliorates Bacillus anthracis lethal toxin-induced lethal pathogenesis in rats. J. Biomed. Sci. 2012;19:98. doi: 10.1186/1423-0127-19-98.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-19-98</ArticleId><ArticleId IdType="pmc">PMC3536616</ArticleId><ArticleId IdType="pubmed">23170801</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M.S., Sun D.S., Lin Y.C., Cheng C.L., Hung S.C., Chen P.K., Yang J.H., Chang H.H. Nanodiamonds protect skin from ultraviolet B-induced damage in mice. J. Nanobiotechnol. 2015;13:35. doi: 10.1186/s12951-015-0094-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12951-015-0094-4</ArticleId><ArticleId IdType="pmc">PMC4432518</ArticleId><ArticleId IdType="pubmed">25947194</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun D.S., Ho P.H., Chang H.H. Soluble P-selectin rescues viper venom-induced mortality through anti-inflammatory properties and PSGL-1 pathway-mediated correction of hemostasis. Sci. Rep. 2016;6:35868. doi: 10.1038/srep35868.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep35868</ArticleId><ArticleId IdType="pmc">PMC5078805</ArticleId><ArticleId IdType="pubmed">27779216</ArticleId></ArticleIdList></Reference><Reference><Citation>Andre P., Hartwell D., Hrachovinova I., Saffaripour S., Wagner D.D. Pro-coagulant state resulting from high levels of soluble P-selectin in blood. Proc. Natl. Acad. Sci. USA. 2000;97:13835&#x2013;13840. doi: 10.1073/pnas.250475997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.250475997</ArticleId><ArticleId IdType="pmc">PMC17662</ArticleId><ArticleId IdType="pubmed">11095738</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramaniam M., Frenette P.S., Saffaripour S., Johnson R.C., Hynes R.O., Wagner D.D. Defects in hemostasis in P-selectin-deficient mice. Blood. 1996;87:1238&#x2013;1242. doi: 10.1182/blood.V87.4.1238.bloodjournal8741238.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V87.4.1238.bloodjournal8741238</ArticleId><ArticleId IdType="pubmed">8608210</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>